SNSE - Sensei Biotherapeutics Inc
30
-0.500 -1.667%
Share volume: 117,584
Last Updated: 03-06-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.14%
PREVIOUS CLOSE
CHG
CHG%
$30.50
-0.50
-0.02%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 09-30-2025 | |
|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q3 2025 | |
| Report Date | 05-09-2024 | 08-06-2024 | 11-14-2024 | 03-28-2025 | 05-06-2025 | 11-14-2025 | |
| Total revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Cost of revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Gross profit | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| nan% | nan% | nan% | nan% | ||||
| Operating expenses | 8.730 M | 7.787 M | 7.823 M | 7.323 M | 7.274 M | 4.851 M | |
| Selling general and admin | 3.813 M | 3.203 M | 3.186 M | 2.834 M | 3.549 M | 2.315 M | |
| Research and development | 4.917 M | 4.584 M | 4.637 M | 4.489 M | 3.725 M | 2.536 M | |
| Total expenses | 8.730 M | 7.787 M | 7.823 M | 8.274 M | 7.254 M | 4.852 M | |
| -10.80% | 0.46% | 5.77% | -12.33% | -33.11% | |||
| Operating income | -8.730 M | -7.787 M | -7.823 M | -8.274 M | -7.274 M | -4.851 M | |
| Ebit | -8.732 M | -7.787 M | -7.823 M | -8.272 M | -7.276 M | -4.851 M | |
| Pretax income | -7.992 M | -7.142 M | -7.253 M | -7.767 M | -6.884 M | -4.568 M | |
| -10.64% | 1.55% | 7.09% | -11.37% | -33.64% | |||
| Income tax | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income basic | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income | -7.992 M | -7.142 M | -7.253 M | -7.770 M | -6.864 M | -4.569 M | |
| 10.64% | -1.55% | -7.13% | 11.66% | 33.44% |